Harmony Gold Mining Co. vs Zimmer Biomet Holdings Inc — how do they compare? Harmony Gold Mining Co. trades at $16.88 (market cap $10.02B), while Zimmer Biomet Holdings Inc trades at $89.14 (market cap $16.95B). The key difference: Zimmer Biomet Holdings Inc is the larger of the two by market cap, and Harmony Gold Mining Co. pays the higher dividend (4.63%). Which is the better fit depends on your goals — on Pluang, investors hold Harmony Gold Mining Co. for 45 Days and Zimmer Biomet Holdings Inc for 89 Days on average.
| HMY | ZBH | |
|---|---|---|
Market Cap | $10.02B | $16.95B |
Volume | 3,643,683 | 2,505,240 |
Sector | Basic Materials | Health |
52-Week High | $26.04 | $103.98 |
52-Week Low | $13.32 | $79.58 |
Typical Hold Time | 45 Days | 89 Days |
Enterprise Value | $10.07B | $24.02B |
Dividend Yield | 4.63% | 1.08% |
Signals from Pluang's Aura AI — not financial advice
Harmony Gold Mining (HMY) trades at $16.84, up 2.12% today, while showing strong fundamental performance with record revenue of $73.90B in 2025 and net income of $14.38B. The stock exhibits bearish technical signals with moving averages indicating selling pressure, though RSI levels suggest potential oversold conditions. Recent earnings show mixed results with two beats and two misses in the last four quarters, while analyst consensus remains cautious with 70% hold ratings.
HMY presents a value opportunity with attractive valuation multiples (P/E 6.02, EV/EBITDA 3.54) and robust profitability metrics (ROE 46.23%, net margin 29.57%). However, investors face risks from the company's significant capital expenditure plans and gold price volatility. The transition to copper production offers long-term growth potential but requires careful monitoring of execution and market conditions.
Zimmer Biomet (ZBH) trades at $88.91, up 0.47% today, with a bearish technical signal from moving averages. The company reported Q2 2026 EPS of $2.07, beating estimates, and raised its 2026 outlook. Revenue growth remains steady, with 2025 revenue at $8.23B, though net income margin declined to 8.56%. The stock is supported by a quarterly dividend of $0.24 and a consensus price target of $103.11, suggesting potential upside.
The outlook is mixed: strong fundamentals and analyst optimism contrast with technical weakness. Investment opportunities include consistent earnings beats and dividend income, but risks involve rising debt levels and competitive pressures in the medical technology sector. The stock's current valuation at a P/E of 21.57 appears reasonable if growth continues.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
Harmony Gold Mining Co Ltd is a gold mining and exploration company having operations in South Africa and Papua New Guinea (PNG). Its projects include Bambanani, Joel, Masimong, Phakisa, Target 1, Tshepong, Unisel, Doornkop, and Kusasalethu. The group's segments are Tshepong Operations, Bambanani, Joel, Doornkop, Moab Khotsong, Hidden Valley, Target 1, Kusasalethu, Masimong, Unisel, and all other surface operations.
Read more on HMY →Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants, as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly 70% of total revenue is derived from sales of large joints, another quarter comes from extremities, trauma, and related surgical products.
Read more on ZBH →